T. Walsh

Molecular Medicine · Lancet. Infectious Diseases (Print) · 2005–2022

A researcher in the Science corpus: 13 papers; trusts 1 researcher and is trusted by 5 researchers here, as inferred from the citation graph.

Subfields

• Molecular Medicine — 46 citations into it; #56 of 296 by trust here, #13 by citations

Whom T. Walsh trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. P. Nordmann

Who trusts T. Walsh overall

1. P. Nordmann
2. L. Poirel
3. G. Meletis
4. T. Naas
5. L. Logan
6. F. Codjoe
7. J. Munita
8. Robert A. Bonomo
9. D. van Duin
10. K. Bush

Papers from T. Walsh's perspective

Ordered by how strongly the researchers T. Walsh trusts endorse each paper. Same corpus, a different order for every researcher.

1. Resistance in gram-negative bacteria: enterobacteriaceae. (American Journal of Medicine)
2. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. (International Journal of Antimicrobial Agents)
3. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis (Lancet. Infectious Diseases (Print))
4. Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. (Clinical Infectious Diseases)
5. Marine natural products. (Natural product reports (Print))
6. World health organization releases global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics
7. Incidence and Trends of Sepsis in US Hospitals Using Clinical vs Claims Data, 2009-2014 (Journal of the American Medical Association (JAMA))
8. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 (The Lancet)
9. Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study… (The Lancet)
10. GBD 2010: design, definitions, and metrics. (The Lancet)

Their papers

• Genetic mechanisms of critical illness in COVID-19 (2020) — 1,244 citations
• Metallo-β-Lactamases: the Quiet before the Storm? (2005) — 1,397 citations
• Crystal Structure of Pseudomonas aeruginosa SPM-1 Provides Insights into Variable Zinc Affinity of Metallo-β-lactamases (2006) — 98 citations
• Tackling antibiotic resistance (2011) — 726 citations
• Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis (2022) — 9,639 citations
• Emergence of plasmid-mediated high-level tigecycline resistance genes in animals and humans (2019) — 594 citations
• Anthropological and socioeconomic factors contributing to global antimicrobial resistance: a univariate and multivariable analysis. (2018) — 598 citations
• Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. (2016) — 4,776 citations
• The emerging NDM carbapenemases. (2011) — 648 citations
• Multiplex PCR for detection of acquired carbapenemase genes. (2011) — 1,826 citations
• Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. (2011) — 1,245 citations
• Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study (2010) — 2,893 citations
• Characterization of a New Metallo-β-Lactamase Gene, blaNDM-1, and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India (2009) — 2,458 citations